[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Active Pharmaceutical Ingredients (API) Market Analysis 2016-2020 and Forecast 2021-2026

March 2021 | 97 pages | ID: G63A5A9B01F5EN
99Strategy

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
SNAPSHOT

The global Active Pharmaceutical Ingredients (API) market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Active Pharmaceutical Ingredients (API) by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
  • Vitamin
  • Antibiotics
  • Antipyretic & Analgesic
  • Hormone
  • Amino Acid
  • Nervus Centralis
  • Others
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
  • Teva Active Pharmaceutical Industries Limited
  • DSM
  • Novartis
  • Roche
  • Johnson & Johnson
  • Dr. Reddy s
  • Pfizer
  • Bayer
  • BASF
  • Cambrex
  • Sun Pharmaceutical Industries
  • Lonza group
  • Boehringer Ingelheim GmbH
  • Aurobindo pharma
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
  • Hospital
  • Clinic
  • Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)
1 INDUSTRY OVERVIEW

1.1 Active Pharmaceutical Ingredients (API) Industry
Figure Active Pharmaceutical Ingredients (API) Industry Chain Structure
  1.1.1 Overview
  1.1.2 Development of Active Pharmaceutical Ingredients (API)
1.2 Market Segment
  1.2.1 Upstream
Table Upstream Segment of Active Pharmaceutical Ingredients (API)
  1.2.2 Downstream
Table Application Segment of Active Pharmaceutical Ingredients (API)
Table Global Active Pharmaceutical Ingredients (API) Market 2016-2026, by Application, in USD Million
  1.2.3 COVID-19 Impact
1.3 Cost Analysis

2 INDUSTRY ENVIRONMENT (PEST ANALYSIS)

2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology

3 ACTIVE PHARMACEUTICAL INGREDIENTS (API) MARKET BY TYPE

3.1 By Type
  3.1.1 Vitamin
Table Major Company List of Vitamin
  3.1.2 Antibiotics
Table Major Company List of Antibiotics
  3.1.3 Antipyretic & Analgesic
Table Major Company List of Antipyretic & Analgesic
  3.1.4 Hormone
Table Major Company List of Hormone
  3.1.5 Amino Acid
Table Major Company List of Amino Acid
  3.1.6 Nervus Centralis
Table Major Company List of Nervus Centralis
  3.1.7 Others
Table Major Company List of Others
3.2 Market Size
Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Type, in USD Million
Figure Global Active Pharmaceutical Ingredients (API) Market Growth 2016-2020, by Type, in USD Million
Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Type, in Volume
Figure Global Active Pharmaceutical Ingredients (API) Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Type, in USD Million
Table Global Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Type, in Volume

4 MAJOR COMPANIES LIST

4.1 Teva Active Pharmaceutical Industries Limited (Company Profile, Sales Data etc.)
  4.1.1 Teva Active Pharmaceutical Industries Limited Profile
Table Teva Active Pharmaceutical Industries Limited Overview List
  4.1.2 Teva Active Pharmaceutical Industries Limited Products & Services
  4.1.3 Teva Active Pharmaceutical Industries Limited Business Operation Conditions
Table Business Operation of Teva Active Pharmaceutical Industries Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 DSM (Company Profile, Sales Data etc.)
  4.2.1 DSM Profile
Table DSM Overview List
  4.2.2 DSM Products & Services
  4.2.3 DSM Business Operation Conditions
Table Business Operation of DSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis (Company Profile, Sales Data etc.)
  4.3.1 Novartis Profile
Table Novartis Overview List
  4.3.2 Novartis Products & Services
  4.3.3 Novartis Business Operation Conditions
Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Roche (Company Profile, Sales Data etc.)
  4.4.1 Roche Profile
Table Roche Overview List
  4.4.2 Roche Products & Services
  4.4.3 Roche Business Operation Conditions
Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Johnson & Johnson (Company Profile, Sales Data etc.)
  4.5.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
  4.5.2 Johnson & Johnson Products & Services
  4.5.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Dr. Reddy s (Company Profile, Sales Data etc.)
  4.6.1 Dr. Reddy s Profile
Table Dr. Reddy s Overview List
  4.6.2 Dr. Reddy s Products & Services
  4.6.3 Dr. Reddy s Business Operation Conditions
Table Business Operation of Dr. Reddy s (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Pfizer (Company Profile, Sales Data etc.)
  4.7.1 Pfizer Profile
Table Pfizer Overview List
  4.7.2 Pfizer Products & Services
  4.7.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Bayer (Company Profile, Sales Data etc.)
  4.8.1 Bayer Profile
Table Bayer Overview List
  4.8.2 Bayer Products & Services
  4.8.3 Bayer Business Operation Conditions
Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 BASF (Company Profile, Sales Data etc.)
  4.9.1 BASF Profile
Table BASF Overview List
  4.9.2 BASF Products & Services
  4.9.3 BASF Business Operation Conditions
Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Cambrex (Company Profile, Sales Data etc.)
  4.10.1 Cambrex Profile
Table Cambrex Overview List
  4.10.2 Cambrex Products & Services
  4.10.3 Cambrex Business Operation Conditions
Table Business Operation of Cambrex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Sun Pharmaceutical Industries (Company Profile, Sales Data etc.)
  4.11.1 Sun Pharmaceutical Industries Profile
Table Sun Pharmaceutical Industries Overview List
  4.11.2 Sun Pharmaceutical Industries Products & Services
  4.11.3 Sun Pharmaceutical Industries Business Operation Conditions
Table Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Lonza group (Company Profile, Sales Data etc.)
  4.12.1 Lonza group Profile
Table Lonza group Overview List
  4.12.2 Lonza group Products & Services
  4.12.3 Lonza group Business Operation Conditions
Table Business Operation of Lonza group (Sales Revenue, Cost, Gross Margin)
4.13 Boehringer Ingelheim GmbH (Company Profile, Sales Data etc.)
  4.13.1 Boehringer Ingelheim GmbH Profile
Table Boehringer Ingelheim GmbH Overview List
  4.13.2 Boehringer Ingelheim GmbH Products & Services
  4.13.3 Boehringer Ingelheim GmbH Business Operation Conditions
Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Aurobindo pharma (Company Profile, Sales Data etc.)
  4.14.1 Aurobindo pharma Profile
Table Aurobindo pharma Overview List
  4.14.2 Aurobindo pharma Products & Services
  4.14.3 Aurobindo pharma Business Operation Conditions
Table Business Operation of Aurobindo pharma (Sales Revenue, Cost, Gross Margin)

5 MARKET COMPETITION

5.1 Company Competition
Table Global Active Pharmaceutical Ingredients (API) Sales Revenue 2016-2020, by Company, in USD Million
Table Global Active Pharmaceutical Ingredients (API) Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Active Pharmaceutical Ingredients (API) Sales Revenue Share in 2020, by Company, in USD Million
Table Global Active Pharmaceutical Ingredients (API) Sales Volume 2016-2020, by Company, in Volume
Table Global Active Pharmaceutical Ingredients (API) Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Active Pharmaceutical Ingredients (API) Market Concentration, in 2020
Figure Europe Active Pharmaceutical Ingredients (API) Market Market Concentration, in 2020
Figure Asia-Pacific Active Pharmaceutical Ingredients (API) MMarket Concentration, in 2020
Figure South America Active Pharmaceutical Ingredients (API) Market Concentration, in 2020
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Market Concentration, in 2020

6 DEMAND BY END MARKET

6.1 Demand Situation
  6.1.1 Demand in Hospital
Figure Active Pharmaceutical Ingredients (API) Demand in Hospital, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredients (API) Demand in Hospital, 2016-2020, in Volume
  6.1.2 Demand in Clinic
Figure Active Pharmaceutical Ingredients (API) Demand in Clinic, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredients (API) Demand in Clinic, 2016-2020, in Volume
  6.1.3 Demand in Others
Figure Active Pharmaceutical Ingredients (API) Demand in Others, 2016-2020, in USD Million
Figure Active Pharmaceutical Ingredients (API) Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Active Pharmaceutical Ingredients (API) Demand Forecast 2021-2026, by Application, in USD Million
Figure Active Pharmaceutical Ingredients (API) Market Growth 2021-2026, by Application, in USD Million
Figure Active Pharmaceutical Ingredients (API) Market Share in 2026, by Application, in USD Million
Table Active Pharmaceutical Ingredients (API) Demand Forecast 2021-2026, by Application, in Volume
Table Active Pharmaceutical Ingredients (API) Market Growth 2021-2026, by Application, in Volume
Table Active Pharmaceutical Ingredients (API) Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand

7 REGION OPERATION

7.1 Regional Production
Table Active Pharmaceutical Ingredients (API) Production 2016-2020, by Region, in USD Million
Table Active Pharmaceutical Ingredients (API) Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Region, in USD Million
Table Global Active Pharmaceutical Ingredients (API) Market Share 2016-2020, by Region, in USD Million
Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Region, in Volume
Table Global Active Pharmaceutical Ingredients (API) Market Share 2016-2020, by Region, in Volume
7.3 by Region
  7.3.1 North America
    7.3.1.1 Overview
Figure North America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
Figure North America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
    7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
Table North America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
  7.3.2 Europe
    7.3.2.1 Overview
Figure Europe Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
Figure Europe Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
    7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
Table Europe Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
  7.3.3 Asia-Pacific
    7.3.3.1 Overview
Figure Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
    7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
  7.3.4 South America
    7.3.4.1 Overview
Figure South America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
Figure South America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
    7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
Table South America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
  7.3.5 Middle East & Africa
    7.3.5.1 Overview
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
    7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Region, in USD Million
Table Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Region, in Volume

8 MARKETING & PRICE

8.1 Price and Margin
  8.1.1 Price Trends
  8.1.2 Factors of Price Change
Table Price Factors List
  8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview

9 RESEARCH CONCLUSION
LIST OF TABLES
1. Table Upstream Segment of Active Pharmaceutical Ingredients (API)
2. Table Application Segment of Active Pharmaceutical Ingredients (API)
3. Table Global Active Pharmaceutical Ingredients (API) Market 2016-2026, by Application, in USD Million
4. Table Major Company List of Antibiotics
5. Table Major Company List of Antipyretic & Analgesic
6. Table Major Company List of Hormone
7. Table Major Company List of Amino Acid
8. Table Major Company List of Nervus Centralis
9. Table Major Company List of Others
10. Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Type, in USD Million
11. Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Type, in Volume
12. Table Global Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Type, in USD Million
13. Table Global Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Type, in Volume
14. Table Teva Active Pharmaceutical Industries Limited Overview List
15. Table Business Operation of Teva Active Pharmaceutical Industries Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
16. Table DSM Overview List
17. Table Business Operation of DSM (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
18. Table Novartis Overview List
19. Table Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
20. Table Roche Overview List
21. Table Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
22. Table Johnson & Johnson Overview List
23. Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
24. Table Dr. Reddy s Overview List
25. Table Business Operation of Dr. Reddy s (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
26. Table Pfizer Overview List
27. Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
28. Table Bayer Overview List
29. Table Business Operation of Bayer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
30. Table BASF Overview List
31. Table Business Operation of BASF (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
32. Table Cambrex Overview List
33. Table Business Operation of Cambrex (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
34. Table Sun Pharmaceutical Industries Overview List
35. Table Business Operation of Sun Pharmaceutical Industries (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
36. Table Lonza group Overview List
37. Table Business Operation of Lonza group (Sales Revenue, Cost, Gross Margin)
38. Table Boehringer Ingelheim GmbH Overview List
39. Table Business Operation of Boehringer Ingelheim GmbH (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
40. Table Aurobindo pharma Overview List
41. Table Business Operation of Aurobindo pharma (Sales Revenue, Cost, Gross Margin)
42. Table Global Active Pharmaceutical Ingredients (API) Sales Revenue 2016-2020, by Company, in USD Million
43. Table Global Active Pharmaceutical Ingredients (API) Sales Revenue Share 2016-2020, by Company, in USD Million
44. Table Global Active Pharmaceutical Ingredients (API) Sales Volume 2016-2020, by Company, in Volume
45. Table Global Active Pharmaceutical Ingredients (API) Sales Volume Share 2016-2020, by Company, in Volume
46. Table Regional Demand Comparison List
47. Table Major Application in Different Regions
48. Table Active Pharmaceutical Ingredients (API) Demand Forecast 2021-2026, by Application, in USD Million
49. Table Active Pharmaceutical Ingredients (API) Demand Forecast 2021-2026, by Application, in Volume
50. Table Active Pharmaceutical Ingredients (API) Market Growth 2021-2026, by Application, in Volume
51. Table Active Pharmaceutical Ingredients (API) Market Share in 2026, by Application, in Volume
52. Table Active Pharmaceutical Ingredients (API) Production 2016-2020, by Region, in USD Million
53. Table Active Pharmaceutical Ingredients (API) Production 2016-2020, by Region, in Volume
54. Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Region, in USD Million
55. Table Global Active Pharmaceutical Ingredients (API) Market Share 2016-2020, by Region, in USD Million
56. Table Global Active Pharmaceutical Ingredients (API) Market 2016-2020, by Region, in Volume
57. Table Global Active Pharmaceutical Ingredients (API) Market Share 2016-2020, by Region, in Volume
58. Table North America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
59. Table North America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
60. Table Europe Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
61. Table Europe Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
62. Table Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
63. Table Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
64. Table South America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
65. Table South America Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
66. Table Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in USD Million
67. Table Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size 2016-2020, by Country, in Volume
68. Table Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Region, in USD Million
69. Table Active Pharmaceutical Ingredients (API) Market Forecast 2021-2026, by Region, in Volume
70. Table Price Factors List
LIST OF FIGURES
1. Figure Active Pharmaceutical Ingredients (API) Industry Chain Structure
2. Figure Global Active Pharmaceutical Ingredients (API) Market Growth 2016-2020, by Type, in USD Million
3. Figure Global Active Pharmaceutical Ingredients (API) Market Growth 2016-2020, by Type, in Volume
4. Figure Global Active Pharmaceutical Ingredients (API) Sales Revenue Share in 2020, by Company, in USD Million
5. Figure Global Active Pharmaceutical Ingredients (API) Sales Volume Share in 2020, by Company, in Volume
6. Figure North America Active Pharmaceutical Ingredients (API) Market Concentration, in 2020
7. Figure Europe Active Pharmaceutical Ingredients (API) Market Market Concentration, in 2020
8. Figure Asia-Pacific Active Pharmaceutical Ingredients (API) MMarket Concentration, in 2020
9. Figure South America Active Pharmaceutical Ingredients (API) Market Concentration, in 2020
10. Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Market Concentration, in 2020
11. Figure Active Pharmaceutical Ingredients (API) Demand in Hospital, 2016-2020, in USD Million
12. Figure Active Pharmaceutical Ingredients (API) Demand in Hospital, 2016-2020, in Volume
13. Figure Active Pharmaceutical Ingredients (API) Demand in Clinic, 2016-2020, in USD Million
14. Figure Active Pharmaceutical Ingredients (API) Demand in Clinic, 2016-2020, in Volume
15. Figure Active Pharmaceutical Ingredients (API) Demand in Others, 2016-2020, in USD Million
16. Figure Active Pharmaceutical Ingredients (API) Demand in Others, 2016-2020, in Volume
17. Figure Active Pharmaceutical Ingredients (API) Market Growth 2021-2026, by Application, in USD Million
18. Figure Active Pharmaceutical Ingredients (API) Market Share in 2026, by Application, in USD Million
19. Figure North America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
20. Figure North America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
21. Figure Europe Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
22. Figure Europe Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
23. Figure Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
24. Figure Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
25. Figure South America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
26. Figure South America Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
27. Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in USD Million
28. Figure Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size and Growth 2016-2020, in Volume
29. Figure Marketing Channels Overview


More Publications